Fort Washington Investment Advisors Inc. OH reduced its stake in shares of Danaher Co. (NYSE:DHR – Free Report) by 1.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 10,944 shares of the conglomerate’s stock after selling 160 shares during the period. Fort Washington Investment Advisors Inc. OH’s holdings in Danaher were worth $2,512,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also made changes to their positions in the company. FMR LLC lifted its stake in Danaher by 15.8% during the third quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock worth $6,566,116,000 after purchasing an additional 3,217,631 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its stake in Danaher by 17.6% during the third quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate’s stock worth $996,141,000 after purchasing an additional 535,254 shares in the last quarter. International Assets Investment Management LLC lifted its stake in Danaher by 40,196.5% during the third quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate’s stock worth $119,539,000 after purchasing an additional 428,897 shares in the last quarter. Montrusco Bolton Investments Inc. lifted its stake in Danaher by 30.4% during the third quarter. Montrusco Bolton Investments Inc. now owns 1,705,884 shares of the conglomerate’s stock worth $465,617,000 after purchasing an additional 397,671 shares in the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec lifted its stake in Danaher by 82.4% during the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 653,375 shares of the conglomerate’s stock worth $181,651,000 after purchasing an additional 295,187 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of research analysts have commented on the company. KeyCorp upped their price target on Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 23rd. Robert W. Baird decreased their price target on Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. Raymond James cut their price objective on Danaher from $300.00 to $275.00 and set an “outperform” rating on the stock in a research report on Tuesday. Evercore ISI upped their price objective on Danaher from $275.00 to $278.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 1st. Finally, Stifel Nicolaus upped their price objective on Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a research report on Wednesday, October 23rd. Six research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $285.55.
Danaher Stock Performance
Shares of DHR stock opened at $245.73 on Friday. The stock’s 50-day moving average is $234.90 and its two-hundred day moving average is $253.47. The firm has a market cap of $177.49 billion, a price-to-earnings ratio of 46.90, a PEG ratio of 4.43 and a beta of 0.83. Danaher Co. has a 1 year low of $225.42 and a 1 year high of $281.70. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37.
Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.14. The company had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same quarter last year, the company posted $2.02 earnings per share. Analysts predict that Danaher Co. will post 7.5 earnings per share for the current year.
Danaher Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be issued a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.44%. The ex-dividend date is Friday, December 27th. Danaher’s payout ratio is 20.61%.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Stories
- Five stocks we like better than Danaher
- How to Use the MarketBeat Dividend Calculator
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- Best Stocks Under $5.00
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- How to Effectively Use the MarketBeat Ratings Screener
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.